Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Dipesh Navsaria MPH, MSLIS, MD
Dipesh Navsaria MPH, MSLIS, MD Advisory Board
Robert Bonakdar MD, FAAFP, FACN
Robert Bonakdar MD, FAAFP, FACN Advisory Board
Nekesha Oliphant MD
Nekesha Oliphant MD Advisory Board
See All Experts
featured
Published in Primary Care

Expert Opinion / Interview · July 18, 2013

A Review on Drug Interactions and Cytochrome P450

Peter Lin MD, CCFP

 

 Save  Recommend
 Share

Additional Info

  1. Yip VL, Pirmohamed M. Expanding role of pharmacogenomics in the management of cardiovascular disorders. Am J Caradiovasc Drugs. Jun;13(3):151-62.

  2. Hong H, Jawaid A, Wang J, et al. Research Highlights: Highlights from the latest research in cytochromes pharmacogenomics. Pharmacogenomics. 2013;14(5):459-463.

  3. Munro AW, Girvan HM, Mason AE, et al. What makes a P450 tick? Trends Biochem Sci. 2013;38(3):140-150.

  4. Division of Clinical Pharmacology, Indiana University. P450 Drug Interaction Table. http://medicine.iupui.edu/clinpharm/ddis/table.aspx. Accessed April 15, 2013.

Disclosure statements are available on the authors' profiles:

Peter Lin MD, CCFP

Further Reading

Most Read This Week

Recently Updated